The Choice between Intravenous and Subcutaneous Immunoglobulins: Aspects for Consideration
Sign Up to like & getrecommendations! Published in 2022 at "Pharmacology"
DOI: 10.1159/000527655
Abstract: Background: Intravenous immunoglobulin and subcutaneous immunoglobulin preparations are used to treat primary and secondary immunodeficiencies, as well as autoimmune and inflammatory conditions. Summary: For certain indications, only defined formulations or routes of administration are approved… read more here.
Keywords: intravenous subcutaneous; pharmacology; aspects consideration; subcutaneous immunoglobulins ... See more keywords
Clinical and Neurophysiological Follow-Up of Chronic Inflammatory Demyelinating Polyneuropathy Patients Treated with Subcutaneous Immunoglobulins: A Real-Life Single Center Study
Sign Up to like & getrecommendations! Published in 2022 at "Brain Sciences"
DOI: 10.3390/brainsci13010010
Abstract: Background: chronic idiopathic demyelinating polyneuropathy (CIDP) is an acquired, immune-mediated neuropathy characterized by weakness, sensory symptoms and significant reduction or loss of deep tendon reflexes evolving over 2 months at least, associated with electrophysiological evidence… read more here.
Keywords: demyelinating polyneuropathy; cidp; subcutaneous immunoglobulins; neurophysiological follow ... See more keywords